164 related articles for article (PubMed ID: 11994286)
1. Basic residues in azurocidin/HBP contribute to both heparin binding and antimicrobial activity.
McCabe D; Cukierman T; Gabay JE
J Biol Chem; 2002 Jul; 277(30):27477-88. PubMed ID: 11994286
[TBL] [Abstract][Full Text] [Related]
2. Binding of bovine pancreatic trypsin inhibitor to heparin binding protein/CAP37/azurocidin. Interaction between a Kunitz-type inhibitor and a proteolytically inactive serine proteinase homologue.
Petersen LC; Birktoft JJ; Flodgaard H
Eur J Biochem; 1993 May; 214(1):271-9. PubMed ID: 7685280
[TBL] [Abstract][Full Text] [Related]
3. Two mutants of human heparin binding protein (CAP37): toward the understanding of the nature of lipid A/LPS and BPTI binding.
Kastrup JS; Linde V; Pedersen AK; Stoffer B; Iversen LF; Larsen IK; Rasmussen PB; Flodgaard HJ; Bjørn SE
Proteins; 2001 Mar; 42(4):442-51. PubMed ID: 11170199
[TBL] [Abstract][Full Text] [Related]
4. Azurocidin, a natural antibiotic from human neutrophils: expression, antimicrobial activity, and secretion.
Almeida RP; Vanet A; Witko-Sarsat V; Melchior M; McCabe D; Gabay JE
Protein Expr Purif; 1996 Jun; 7(4):355-66. PubMed ID: 8776752
[TBL] [Abstract][Full Text] [Related]
5. Azurocidin -- inactive serine proteinase homolog acting as a multifunctional inflammatory mediator.
Watorek W
Acta Biochim Pol; 2003; 50(3):743-52. PubMed ID: 14515154
[TBL] [Abstract][Full Text] [Related]
6. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.
Campanelli D; Detmers PA; Nathan CF; Gabay JE
J Clin Invest; 1990 Mar; 85(3):904-15. PubMed ID: 2312733
[TBL] [Abstract][Full Text] [Related]
7. Atomic resolution structure of human HBP/CAP37/azurocidin.
Karlsen S; Iversen LF; Larsen IK; Flodgaard HJ; Kastrup JS
Acta Crystallogr D Biol Crystallogr; 1998 Jul; 54(Pt 4):598-609. PubMed ID: 9761855
[TBL] [Abstract][Full Text] [Related]
8. Analysis of individual azurocidin N-glycosylation sites in regard to its secretion by insect cells, susceptibility to proteolysis and antibacterial activity.
Indyk K; Olczak T; Ciuraszkiewicz J; Watorek W; Olczak M
Acta Biochim Pol; 2007; 54(3):567-73. PubMed ID: 17653303
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of the N-linked glycans of HBP/CAP37/azurocidin: crystal structure determination and biological characterization of nonglycosylated HBP.
Iversen LF; Kastrup JS; Bjørn SE; Wiberg FC; Larsen IK; Flodgaard HJ; Rasmussen PB
Protein Sci; 1999 Oct; 8(10):2019-26. PubMed ID: 10548047
[TBL] [Abstract][Full Text] [Related]
10. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles.
Tapper H; Karlsson A; Mörgelin M; Flodgaard H; Herwald H
Blood; 2002 Mar; 99(5):1785-93. PubMed ID: 11861296
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activities of heparin-binding peptides.
Andersson E; Rydengård V; Sonesson A; Mörgelin M; Björck L; Schmidtchen A
Eur J Biochem; 2004 Mar; 271(6):1219-26. PubMed ID: 15009200
[TBL] [Abstract][Full Text] [Related]
12. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils.
Chertov O; Michiel DF; Xu L; Wang JM; Tani K; Murphy WJ; Longo DL; Taub DD; Oppenheim JJ
J Biol Chem; 1996 Feb; 271(6):2935-40. PubMed ID: 8621683
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation.
Heinzelmann M; Mercer-Jones MA; Flodgaard H; Miller FN
J Immunol; 1998 Jun; 160(11):5530-6. PubMed ID: 9605157
[TBL] [Abstract][Full Text] [Related]
14. Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle.
Busby TF; Argraves WS; Brew SA; Pechik I; Gilliland GL; Ingham KC
J Biol Chem; 1995 Aug; 270(31):18558-62. PubMed ID: 7629186
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of human azurocidin catalytic triad and proteolytic activity by site-directed mutagenesis.
Olczak M; Indyk K; Olczak T
Biol Chem; 2008 Jul; 389(7):955-62. PubMed ID: 18627314
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine sulfate-rich domains of the LRR proteins fibromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin-binding proteins, including bioactive factors.
Tillgren V; Onnerfjord P; Haglund L; Heinegård D
J Biol Chem; 2009 Oct; 284(42):28543-53. PubMed ID: 19700767
[TBL] [Abstract][Full Text] [Related]
17. Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes.
Rasmussen PB; Bjørn S; Hastrup S; Nielsen PF; Norris K; Thim L; Wiberg FC; Flodgaard H
FEBS Lett; 1996 Jul; 390(1):109-12. PubMed ID: 8706818
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin).
Di Gennaro A; Kenne E; Wan M; Soehnlein O; Lindbom L; Haeggström JZ
FASEB J; 2009 Jun; 23(6):1750-7. PubMed ID: 19151333
[TBL] [Abstract][Full Text] [Related]
19. Binding between azurocidin and calreticulin: its involvement in the activation of peripheral monocytes.
Okuyama Y; Cho JH; Nakajima Y; Homma K; Sekimizu K; Natori S
J Biochem; 2004 Feb; 135(2):171-7. PubMed ID: 15047718
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the biosynthesis, processing, and sorting of human HBP/CAP37/azurocidin.
Lindmark A; Garwicz D; Rasmussen PB; Flodgaard H; Gullberg U
J Leukoc Biol; 1999 Oct; 66(4):634-43. PubMed ID: 10534120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
